Nephros (NEPH) EPS (Basic) (QoQ) (2010 - 2026)
Nephros (NEPH) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.48 Bn | 128.26 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.15 Bn | 51.29 Bn | 2.32 Bn |
| 3 | Alcon | 35.59 Bn | 34.24 Bn | 1.68 Bn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn |
| 5 | Medline | 28.56 Bn | 25.88 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn |
| 10 | Nephros | 46.36 Mn | 41.66 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 229.05% |
| Mar 31, 2026 | -53.40% |
| Dec 31, 2025 | -81.60% |
| Sep 30, 2025 | 42.04% |
| Jun 30, 2025 | 126.36% |
| Mar 31, 2025 | -345.23% |
| Dec 31, 2024 | 99.27% |
| Sep 30, 2024 | 163.12% |
| Jun 30, 2024 | -38.83% |
| Mar 31, 2024 | 68.55% |
| Dec 31, 2023 | -261.93% |
| Sep 30, 2023 | 58.62% |
| Jun 30, 2023 | -41.50% |
| Mar 31, 2023 | 66.67% |
| Dec 31, 2022 | 71.57% |
| Sep 30, 2022 | -168.46% |
| Jun 30, 2022 | 41.23% |
| Mar 31, 2022 | -80.51% |
| Dec 31, 2021 | 9.50% |
| Sep 30, 2021 | -1.99% |